Investigations of filovirus propagation and cellular defense mechanisms against filoviruses in the reservoir host Rousettus aegyptiacus and other fruit bat species
丝状病毒在储存宿主埃及野生果蝠和其他果蝠物种中的传播和针对丝状病毒的细胞防御机制的研究
基本信息
- 批准号:226375906
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:德国
- 项目类别:Priority Programmes
- 财政年份:2013
- 资助国家:德国
- 起止时间:2012-12-31 至 2015-12-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Marburg virus (MARV) and Ebola viruses (EBOV), both members of the family Filoviridae, reside in fruit bats in Central Africa and cause sporadic outbreaks in the human population. Filoviral infections in humans lead to a severe hemorrhagic fever with high case-fatality rates, in contrast, fruit bats, the natural reservoir for filoviruses do not seem to show symptoms. Primary target cells for filoviruses in humans are monocytes, macrophages and dendritic cells. Impairment of their function in innate and adaptive immunity leads to massive cytokine secretion and severity of the disease caused by filoviruses. Currently it is not known whether fruit bat derived monocytes, macrophages and dendritic cells are susceptible to filovirus infection and if they play a decisive role during the course of infection.Distinct fruit bat species are described as the potential reservoir for EBOV and MARV. EBOVspecific antibodies were detected in three different fruit bat species: the Hammer-headed Bat, Franquet’s Epauletted Fruit Bat and Little Collared Fruit Bat. MARV-specific RNA and antibodies were found in another fruit bat species the Egyptian Fruit Bat and so far, this is the only species from which infectious MARV has been isolated. MARV and EBOV proliferate unequally well in cells from the Egyptian Fruit Bat. Therefore we presume that virus-specific differences determine their capability to replicate in a specific fruit bat cell.The type-I-interferon (IFN) system is the first effective cellular defense mechanism against viruses and most viruses developed counter strategies that inhibit the IFN system to allow viral replication. Species-specific differences in the capability of viral proteins to inhibit the IFN response can be relevant for the adaptation of viruses to a new host. Nothing is known so far on how the filoviral IFN antagonists (VP35, VP40 and VP24) control the IFN system of fruit bats and whether speciesspecific differences might contribute to reduced pathogenicity of the virus in the reservoir host in comparison to the recipient host.Taken together, very little is known about the differences between reservoir host and recipient species in terms of their ability to replicate or restrict filoviruses. These differences, however, are important to understand on the one hand the pathogenicity of filoviruses in humans and on the other hand the immune system of bats that are able to propagate many viruses that induce severe diseases in men. We would like to investigate (i) the response of immortalized and primary cells of fruit bats to filovirus infection, (ii) the propagation of different virus strains in fruit bat cells, (iii) cellular defense mechanisms against filoviruses in fruit bat derived cells.
马尔堡病毒(MARV)和埃博拉病毒(EBOV)都是丝状病毒科的成员,存在于中非的果蝠体内,并在人群中引起零星爆发。人类的丝状病毒感染会导致严重的出血热,病死率很高,相比之下,果蝠,丝状病毒的天然宿主似乎没有表现出症状。人丝状病毒的主要靶细胞是单核细胞、巨噬细胞和树突细胞。它们在先天性和适应性免疫中的功能受损导致大量细胞因子分泌和由丝状病毒引起的疾病的严重性。目前还不清楚果蝠来源的单核细胞、巨噬细胞和树突状细胞是否对丝状病毒感染敏感,以及它们是否在感染过程中起决定性作用。不同的果蝠物种被描述为EBOV和MARV的潜在宿主。在三种不同的果蝠物种中检测到EBOV特异性抗体:锤头果蝠、Franquet's Epauletted果蝠和小领果蝠。在另一种果蝠物种埃及果蝠中发现了MARV特异性RNA和抗体,到目前为止,这是唯一分离出传染性MARV的物种。MARV和EBOV在埃及果蝠的细胞中增殖得不一样。因此,我们推测,病毒特异性的差异决定了它们在特定的果蝠细胞中复制的能力。I型干扰素(IFN)系统是第一个有效的细胞防御机制,对病毒和大多数病毒开发的计数器策略,抑制IFN系统,使病毒复制。病毒蛋白抑制IFN应答的能力的种属特异性差异可能与病毒对新宿主的适应有关。目前还不清楚丝状病毒IFN拮抗剂(VP35、VP40和VP24)控制果蝠的IFN系统,以及种特异性差异是否可能导致病毒在储存宿主中的致病性比受体宿主低。然而,这些差异对于理解丝状病毒在人类中的致病性和蝙蝠的免疫系统是很重要的,蝙蝠的免疫系统能够传播许多引起人类严重疾病的病毒。我们想研究(i)果蝠的永生细胞和原代细胞对丝状病毒感染的反应,(ii)不同病毒株在果蝠细胞中的繁殖,(iii)果蝠衍生细胞中对丝状病毒的细胞防御机制。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Professor Dr. Stephan Becker其他文献
Professor Dr. Stephan Becker的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Professor Dr. Stephan Becker', 18)}}的其他基金
Targeting immunophilin- and MAPK-associated pathways to inhibit MERS-CoV replication and prevent lung injury
靶向亲免素和 MAPK 相关途径抑制 MERS-CoV 复制并预防肺损伤
- 批准号:
319808243 - 财政年份:
- 资助金额:
-- - 项目类别:
Clinical Research Units
相似海外基金
Defining the protective or pathologic role of antibodies in Post-Ebola Syndrome
定义抗体在埃博拉后综合症中的保护或病理作用
- 批准号:
10752441 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Development of antibody drug conjugates as pan-filo antivirals
开发作为泛型抗病毒药物的抗体药物偶联物
- 批准号:
10759731 - 财政年份:2023
- 资助金额:
-- - 项目类别:
High throughput screening and drug discovery for antagonists of the Ebola VP40 protein assembly
埃博拉 VP40 蛋白组装拮抗剂的高通量筛选和药物发现
- 批准号:
10760573 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Establishment of a Bat Resource for Infectious Disease Research
建立用于传染病研究的蝙蝠资源
- 批准号:
10495114 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Positioning Mason's Regional Biocontainment Laboratory for Effective Pandemic Preparedness
梅森的区域生物防护实验室定位为有效的流行病防范
- 批准号:
10793382 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Mechanisms of antiviral immunity and tolerance in the intestinal epithelium of Jamaican Fruit Bats
牙买加果蝠肠上皮的抗病毒免疫和耐受机制
- 批准号:
10592671 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Prophylactic Immunotherapy for Marburg Virus Disease Outbreak Control
控制马尔堡病毒病暴发的预防性免疫治疗
- 批准号:
10697211 - 财政年份:2023
- 资助金额:
-- - 项目类别:
The Protective and Pathologic Features of the EVD Survivor Immune System
埃博拉病毒病幸存者免疫系统的保护和病理特征
- 批准号:
10639583 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Large-scale compatibility assessments between ACE2 proteins and diverse sarbecovirus spikes
ACE2 蛋白和多种 sarbecovirus 尖峰之间的大规模兼容性评估
- 批准号:
10722852 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Using Bacterial Effectors to Uncover Innate Immune Mechanisms Restricting Viral Replication in Bat Cells
利用细菌效应器揭示蝙蝠细胞中限制病毒复制的先天免疫机制
- 批准号:
10592024 - 财政年份:2023
- 资助金额:
-- - 项目类别: